| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retroviridae Infections | 23 | 2023 | 43 | 5.580 |
Why?
|
| Mammary Tumor Virus, Mouse | 41 | 2017 | 64 | 5.210 |
Why?
|
| Retroviridae | 6 | 2026 | 74 | 2.710 |
Why?
|
| Histocompatibility Antigens Class II | 7 | 2026 | 174 | 2.030 |
Why?
|
| Virus Diseases | 5 | 2019 | 83 | 1.930 |
Why?
|
| Antibodies, Neutralizing | 7 | 2026 | 175 | 1.870 |
Why?
|
| Viruses | 5 | 2019 | 64 | 1.700 |
Why?
|
| Tumor Virus Infections | 17 | 2011 | 83 | 1.680 |
Why?
|
| Mice | 60 | 2026 | 12735 | 1.640 |
Why?
|
| Antibodies, Viral | 12 | 2026 | 341 | 1.500 |
Why?
|
| HLA-D Antigens | 3 | 2021 | 20 | 1.380 |
Why?
|
| Mammary Neoplasms, Experimental | 11 | 2006 | 130 | 1.190 |
Why?
|
| Animals | 64 | 2026 | 28981 | 1.080 |
Why?
|
| Immunity, Innate | 11 | 2019 | 482 | 1.080 |
Why?
|
| Gastrointestinal Microbiome | 4 | 2025 | 661 | 1.080 |
Why?
|
| Symbiosis | 4 | 2022 | 130 | 1.020 |
Why?
|
| Mice, Inbred Strains | 9 | 2023 | 281 | 1.000 |
Why?
|
| Microbiota | 4 | 2025 | 472 | 0.970 |
Why?
|
| Leukemia Virus, Murine | 5 | 2023 | 19 | 0.930 |
Why?
|
| Carcinogenesis | 2 | 2025 | 244 | 0.900 |
Why?
|
| Immunity, Humoral | 2 | 2017 | 76 | 0.890 |
Why?
|
| Immunoglobulins | 2 | 2024 | 124 | 0.850 |
Why?
|
| V(D)J Recombination | 1 | 2024 | 13 | 0.820 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2024 | 453 | 0.820 |
Why?
|
| Superantigens | 9 | 2004 | 24 | 0.750 |
Why?
|
| Metagenome | 3 | 2013 | 123 | 0.750 |
Why?
|
| Polymorphism, Genetic | 3 | 2021 | 832 | 0.740 |
Why?
|
| Bacterial Physiological Phenomena | 2 | 2013 | 44 | 0.730 |
Why?
|
| Staphylococcus aureus | 2 | 2024 | 292 | 0.700 |
Why?
|
| Mice, Inbred C57BL | 18 | 2026 | 3616 | 0.680 |
Why?
|
| Staphylococcal Infections | 1 | 2024 | 287 | 0.670 |
Why?
|
| Adaptive Immunity | 4 | 2019 | 194 | 0.670 |
Why?
|
| Intestines | 3 | 2019 | 442 | 0.650 |
Why?
|
| Leukemia | 1 | 2022 | 309 | 0.630 |
Why?
|
| Mice, Knockout | 10 | 2026 | 2212 | 0.620 |
Why?
|
| Autoimmunity | 1 | 2021 | 195 | 0.620 |
Why?
|
| Virus Physiological Phenomena | 1 | 2019 | 7 | 0.610 |
Why?
|
| Bacteria | 5 | 2023 | 546 | 0.600 |
Why?
|
| Antigens, Viral | 9 | 2011 | 123 | 0.600 |
Why?
|
| Rauscher Virus | 2 | 2017 | 8 | 0.570 |
Why?
|
| Immunoglobulin G | 3 | 2018 | 480 | 0.570 |
Why?
|
| Mice, Inbred C3H | 17 | 2011 | 370 | 0.560 |
Why?
|
| Antigen Presentation | 6 | 2026 | 234 | 0.560 |
Why?
|
| Viral Envelope Proteins | 7 | 2024 | 80 | 0.560 |
Why?
|
| Immune Tolerance | 2 | 2020 | 386 | 0.550 |
Why?
|
| T-Lymphocytes | 11 | 2006 | 1334 | 0.470 |
Why?
|
| Mice, Inbred BALB C | 11 | 2020 | 1110 | 0.470 |
Why?
|
| B-Lymphocytes | 7 | 2026 | 731 | 0.460 |
Why?
|
| Caliciviridae Infections | 1 | 2015 | 10 | 0.440 |
Why?
|
| Norovirus | 1 | 2015 | 13 | 0.440 |
Why?
|
| Gastroenteritis | 1 | 2015 | 26 | 0.430 |
Why?
|
| Mice, Transgenic | 13 | 2025 | 1607 | 0.420 |
Why?
|
| Genes, gag | 3 | 2006 | 7 | 0.410 |
Why?
|
| Mammary Glands, Animal | 9 | 2006 | 82 | 0.400 |
Why?
|
| Chromosome Mapping | 6 | 2020 | 1064 | 0.400 |
Why?
|
| Germ-Free Life | 3 | 2025 | 88 | 0.400 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2023 | 701 | 0.380 |
Why?
|
| Interferon-gamma | 4 | 2018 | 479 | 0.380 |
Why?
|
| Immune Evasion | 2 | 2015 | 37 | 0.370 |
Why?
|
| Cytokines | 2 | 2015 | 891 | 0.360 |
Why?
|
| Disease Susceptibility | 4 | 2023 | 225 | 0.350 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2011 | 16 | 0.340 |
Why?
|
| Mice, Congenic | 2 | 2021 | 12 | 0.340 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2011 | 59 | 0.340 |
Why?
|
| Virus Internalization | 1 | 2011 | 46 | 0.330 |
Why?
|
| Host-Pathogen Interactions | 4 | 2015 | 250 | 0.330 |
Why?
|
| Membrane Glycoproteins | 2 | 2011 | 446 | 0.330 |
Why?
|
| DNA, Viral | 8 | 2006 | 238 | 0.310 |
Why?
|
| Virus Latency | 1 | 2009 | 33 | 0.300 |
Why?
|
| Peptides | 3 | 2021 | 671 | 0.300 |
Why?
|
| Spleen | 3 | 2023 | 376 | 0.290 |
Why?
|
| Neoplasms | 1 | 2025 | 3349 | 0.290 |
Why?
|
| Female | 33 | 2025 | 51761 | 0.280 |
Why?
|
| Hepatitis B | 2 | 2020 | 78 | 0.280 |
Why?
|
| Intestinal Mucosa | 2 | 2019 | 845 | 0.270 |
Why?
|
| Milk | 4 | 2004 | 56 | 0.250 |
Why?
|
| Endogenous Retroviruses | 2 | 2006 | 10 | 0.250 |
Why?
|
| Molecular Sequence Data | 13 | 2006 | 2897 | 0.240 |
Why?
|
| H-2 Antigens | 1 | 2026 | 58 | 0.240 |
Why?
|
| Chronic Disease | 1 | 2009 | 988 | 0.240 |
Why?
|
| Mammals | 2 | 2024 | 268 | 0.240 |
Why?
|
| Virus Replication | 4 | 2013 | 292 | 0.240 |
Why?
|
| Virion | 2 | 2005 | 62 | 0.240 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 6 | 1997 | 130 | 0.230 |
Why?
|
| Recombination, Genetic | 3 | 1997 | 424 | 0.220 |
Why?
|
| Wnt1 Protein | 1 | 2025 | 27 | 0.220 |
Why?
|
| Base Sequence | 11 | 2004 | 2224 | 0.210 |
Why?
|
| Antigens, Viral, Tumor | 3 | 1998 | 14 | 0.210 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2005 | 506 | 0.210 |
Why?
|
| Animals, Newborn | 4 | 2011 | 526 | 0.200 |
Why?
|
| Humans | 17 | 2024 | 98370 | 0.200 |
Why?
|
| Amino Acid Sequence | 7 | 2006 | 2008 | 0.200 |
Why?
|
| Dendritic Cells | 2 | 2026 | 552 | 0.200 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2006 | 464 | 0.200 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2024 | 85 | 0.190 |
Why?
|
| Proviruses | 7 | 2006 | 15 | 0.190 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2014 | 85 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2019 | 2579 | 0.190 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 2577 | 0.180 |
Why?
|
| Metabolomics | 1 | 2023 | 108 | 0.180 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2023 | 321 | 0.180 |
Why?
|
| Blotting, Western | 4 | 2014 | 779 | 0.180 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2025 | 463 | 0.170 |
Why?
|
| Male | 16 | 2025 | 47263 | 0.170 |
Why?
|
| Hematopoiesis | 1 | 2002 | 187 | 0.170 |
Why?
|
| Interleukin-10 | 4 | 2015 | 167 | 0.160 |
Why?
|
| Digestive System | 1 | 2020 | 42 | 0.160 |
Why?
|
| Mice, Inbred CBA | 5 | 2020 | 51 | 0.160 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2015 | 96 | 0.160 |
Why?
|
| HeLa Cells | 2 | 2020 | 520 | 0.150 |
Why?
|
| Interleukins | 3 | 2015 | 135 | 0.150 |
Why?
|
| Peyer's Patches | 1 | 1999 | 19 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 373 | 0.150 |
Why?
|
| Immunity, Mucosal | 1 | 1999 | 71 | 0.150 |
Why?
|
| Antigen-Presenting Cells | 2 | 2001 | 146 | 0.140 |
Why?
|
| RNA, Viral | 3 | 2004 | 288 | 0.140 |
Why?
|
| Receptors, Virus | 1 | 1998 | 74 | 0.130 |
Why?
|
| Sequence Homology, Nucleic Acid | 5 | 1991 | 157 | 0.130 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2020 | 358 | 0.120 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2006 | 89 | 0.120 |
Why?
|
| Computational Biology | 2 | 2017 | 618 | 0.120 |
Why?
|
| Epithelium | 2 | 2014 | 316 | 0.120 |
Why?
|
| Genetic Engineering | 2 | 2006 | 102 | 0.120 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2015 | 23 | 0.120 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 1996 | 59 | 0.110 |
Why?
|
| Neutralization Tests | 2 | 2007 | 74 | 0.110 |
Why?
|
| Hepatitis C | 1 | 2017 | 186 | 0.110 |
Why?
|
| Cloning, Molecular | 5 | 2006 | 582 | 0.110 |
Why?
|
| Antigens, Neoplasm | 2 | 1989 | 365 | 0.110 |
Why?
|
| Species Specificity | 2 | 2014 | 690 | 0.110 |
Why?
|
| Selection, Genetic | 2 | 2003 | 572 | 0.110 |
Why?
|
| Fucose | 1 | 2014 | 15 | 0.110 |
Why?
|
| Crosses, Genetic | 2 | 2006 | 165 | 0.110 |
Why?
|
| Models, Genetic | 2 | 2006 | 1006 | 0.110 |
Why?
|
| Freund's Adjuvant | 1 | 2014 | 25 | 0.100 |
Why?
|
| Lipopolysaccharides | 2 | 2015 | 313 | 0.100 |
Why?
|
| Ovalbumin | 1 | 2014 | 105 | 0.100 |
Why?
|
| Disease | 1 | 2014 | 92 | 0.100 |
Why?
|
| Gene Products, gag | 2 | 2012 | 10 | 0.100 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2014 | 150 | 0.100 |
Why?
|
| Cell Nucleolus | 1 | 2012 | 25 | 0.090 |
Why?
|
| Virus Assembly | 1 | 2012 | 22 | 0.090 |
Why?
|
| Ribosomal Proteins | 1 | 2012 | 47 | 0.090 |
Why?
|
| Poliovirus | 1 | 2012 | 14 | 0.090 |
Why?
|
| Intestine, Small | 1 | 2014 | 321 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2011 | 2858 | 0.090 |
Why?
|
| Viral Core Proteins | 2 | 1989 | 24 | 0.090 |
Why?
|
| Inflammation | 2 | 2020 | 1133 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 2574 | 0.090 |
Why?
|
| Melanoma, Experimental | 2 | 2003 | 114 | 0.090 |
Why?
|
| Milk, Human | 2 | 1989 | 54 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 1998 | 1290 | 0.080 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 1997 | 117 | 0.080 |
Why?
|
| Mice, Inbred DBA | 2 | 2004 | 146 | 0.080 |
Why?
|
| HIV-1 | 1 | 2012 | 180 | 0.080 |
Why?
|
| Genes, env | 3 | 2002 | 8 | 0.080 |
Why?
|
| Endosomes | 1 | 2011 | 91 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2011 | 100 | 0.080 |
Why?
|
| Cell Line | 6 | 2012 | 2483 | 0.080 |
Why?
|
| Pregnancy | 2 | 2011 | 3269 | 0.080 |
Why?
|
| Interferon Type I | 1 | 2011 | 170 | 0.080 |
Why?
|
| Pedigree | 3 | 1998 | 987 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 631 | 0.080 |
Why?
|
| Flow Cytometry | 2 | 2005 | 722 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2015 | 3633 | 0.070 |
Why?
|
| Kidney | 1 | 2014 | 1121 | 0.070 |
Why?
|
| Toll-Like Receptors | 2 | 2014 | 106 | 0.070 |
Why?
|
| Virus Integration | 2 | 2006 | 17 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2006 | 1397 | 0.070 |
Why?
|
| Birds | 1 | 1990 | 180 | 0.070 |
Why?
|
| Transcription, Genetic | 4 | 1999 | 1133 | 0.070 |
Why?
|
| Interferons | 1 | 2007 | 114 | 0.060 |
Why?
|
| Interleukin-12 | 1 | 2007 | 110 | 0.060 |
Why?
|
| Mice, Inbred AKR | 2 | 1997 | 9 | 0.060 |
Why?
|
| Oncogenes | 1 | 1987 | 102 | 0.060 |
Why?
|
| Lymphoid Tissue | 1 | 2006 | 54 | 0.060 |
Why?
|
| Chromosomes | 1 | 2006 | 91 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2006 | 195 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 880 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 137 | 0.060 |
Why?
|
| Breast Neoplasms | 3 | 2016 | 3285 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2006 | 209 | 0.060 |
Why?
|
| Mutation | 1 | 2017 | 4428 | 0.060 |
Why?
|
| Adoptive Transfer | 1 | 2005 | 174 | 0.060 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2005 | 92 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 1998 | 1028 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2005 | 270 | 0.050 |
Why?
|
| Milk Proteins | 2 | 1999 | 24 | 0.050 |
Why?
|
| Haplotypes | 1 | 2006 | 657 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2003 | 994 | 0.050 |
Why?
|
| Terminal Repeat Sequences | 2 | 2004 | 9 | 0.050 |
Why?
|
| Lactation | 2 | 1994 | 57 | 0.050 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2003 | 43 | 0.050 |
Why?
|
| Viral Proteins | 1 | 1985 | 252 | 0.050 |
Why?
|
| 3T3 Cells | 1 | 2002 | 94 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 2 | 2003 | 356 | 0.050 |
Why?
|
| Cross Reactions | 1 | 2003 | 116 | 0.050 |
Why?
|
| Postpartum Period | 1 | 2004 | 169 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2003 | 173 | 0.050 |
Why?
|
| Isoantigens | 1 | 2002 | 74 | 0.050 |
Why?
|
| Gene Expression | 2 | 2019 | 1322 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 403 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 291 | 0.040 |
Why?
|
| Toxoplasmosis, Animal | 1 | 2001 | 19 | 0.040 |
Why?
|
| Genetic Variation | 2 | 2003 | 1454 | 0.040 |
Why?
|
| Enterotoxins | 1 | 2001 | 22 | 0.040 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2020 | 21 | 0.040 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2000 | 17 | 0.040 |
Why?
|
| Protein Binding | 2 | 2015 | 1561 | 0.040 |
Why?
|
| Virus Shedding | 1 | 2000 | 20 | 0.040 |
Why?
|
| Superinfection | 1 | 1999 | 2 | 0.040 |
Why?
|
| Defensins | 1 | 2019 | 5 | 0.040 |
Why?
|
| Genes, Recessive | 1 | 2000 | 88 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2000 | 353 | 0.040 |
Why?
|
| Genes, Immunoglobulin | 1 | 1999 | 62 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2020 | 94 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 228 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1999 | 128 | 0.040 |
Why?
|
| Cell Count | 1 | 1999 | 195 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 1999 | 154 | 0.040 |
Why?
|
| Major Histocompatibility Complex | 1 | 2019 | 89 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 170 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 139 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1990 | 195 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 270 | 0.030 |
Why?
|
| Gene Amplification | 1 | 1998 | 142 | 0.030 |
Why?
|
| COS Cells | 1 | 1998 | 163 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 2896 | 0.030 |
Why?
|
| Homeostasis | 1 | 2020 | 474 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1998 | 380 | 0.030 |
Why?
|
| Phenotype | 1 | 2004 | 2667 | 0.030 |
Why?
|
| Gammaretrovirus | 1 | 1997 | 4 | 0.030 |
Why?
|
| Alleles | 1 | 2020 | 1163 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 1999 | 822 | 0.030 |
Why?
|
| Nucleotides | 1 | 1997 | 93 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 1995 | 894 | 0.030 |
Why?
|
| Reassortant Viruses | 1 | 1996 | 23 | 0.030 |
Why?
|
| Trans-Activators | 1 | 1999 | 447 | 0.030 |
Why?
|
| Cricetinae | 3 | 1991 | 533 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 1996 | 267 | 0.030 |
Why?
|
| Gene Library | 1 | 1995 | 126 | 0.030 |
Why?
|
| Citrobacter rodentium | 1 | 2014 | 14 | 0.030 |
Why?
|
| Fucosyltransferases | 1 | 2014 | 9 | 0.030 |
Why?
|
| Protective Factors | 1 | 2014 | 30 | 0.030 |
Why?
|
| Anorexia | 1 | 2014 | 26 | 0.030 |
Why?
|
| DNA Primers | 1 | 1995 | 530 | 0.030 |
Why?
|
| Glycosylation | 1 | 2014 | 142 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2014 | 43 | 0.030 |
Why?
|
| Clone Cells | 2 | 2003 | 223 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 102 | 0.030 |
Why?
|
| Virulence Factors | 1 | 2014 | 117 | 0.030 |
Why?
|
| Eating | 1 | 2014 | 164 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2014 | 145 | 0.020 |
Why?
|
| DNA Probes | 2 | 1990 | 67 | 0.020 |
Why?
|
| Lupus Nephritis | 1 | 2014 | 85 | 0.020 |
Why?
|
| Ligands | 1 | 2014 | 491 | 0.020 |
Why?
|
| Cell Communication | 1 | 2014 | 223 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2014 | 213 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2012 | 55 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 1999 | 1268 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 2012 | 42 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 139 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 87 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 80 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2012 | 102 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 1992 | 103 | 0.020 |
Why?
|
| Biological Evolution | 2 | 1990 | 1079 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 447 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 1019 | 0.020 |
Why?
|
| Plasmids | 2 | 1991 | 275 | 0.020 |
Why?
|
| Acute Disease | 2 | 2003 | 860 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1992 | 299 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1990 | 107 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1989 | 102 | 0.020 |
Why?
|
| Antibodies, Neoplasm | 1 | 1989 | 87 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2012 | 710 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1987 | 76 | 0.020 |
Why?
|
| Transformation, Genetic | 1 | 1987 | 38 | 0.020 |
Why?
|
| Breast | 1 | 1989 | 316 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1992 | 2070 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1985 | 291 | 0.010 |
Why?
|
| Progesterone | 1 | 1985 | 126 | 0.010 |
Why?
|
| Azacitidine | 1 | 1985 | 152 | 0.010 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2003 | 17 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 2003 | 46 | 0.010 |
Why?
|
| Estradiol | 1 | 1985 | 268 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2004 | 118 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2003 | 76 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2003 | 102 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2003 | 201 | 0.010 |
Why?
|
| Laminin | 1 | 2003 | 89 | 0.010 |
Why?
|
| Listeria monocytogenes | 1 | 2003 | 98 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1985 | 318 | 0.010 |
Why?
|
| Toxoplasmosis | 1 | 2003 | 69 | 0.010 |
Why?
|
| Toxoplasma | 1 | 2003 | 115 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 889 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2003 | 402 | 0.010 |
Why?
|
| Collagen | 1 | 2003 | 313 | 0.010 |
Why?
|
| DNA | 1 | 1987 | 1275 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2001 | 218 | 0.010 |
Why?
|
| Necrosis | 1 | 2001 | 219 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2001 | 278 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2001 | 400 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 917 | 0.010 |
Why?
|
| Cell Division | 1 | 2001 | 690 | 0.010 |
Why?
|
| Transgenes | 1 | 1999 | 173 | 0.010 |
Why?
|
| Incidence | 1 | 2004 | 1787 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2001 | 440 | 0.010 |
Why?
|
| Prolactin | 1 | 1999 | 90 | 0.010 |
Why?
|
| STAT5 Transcription Factor | 1 | 1999 | 44 | 0.010 |
Why?
|
| Transfection | 1 | 1999 | 883 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1997 | 18 | 0.010 |
Why?
|
| Models, Biological | 1 | 2003 | 1805 | 0.010 |
Why?
|
| Clonal Deletion | 1 | 1995 | 24 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1995 | 98 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 1995 | 74 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1995 | 205 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 5577 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1995 | 484 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1992 | 26 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1992 | 287 | 0.010 |
Why?
|
| Rats | 1 | 1997 | 4074 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1991 | 119 | 0.010 |
Why?
|
| Aging | 1 | 1995 | 770 | 0.000 |
Why?
|
| Genomic Library | 1 | 1990 | 30 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1990 | 60 | 0.000 |
Why?
|
| Genes, pol | 1 | 1989 | 3 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1995 | 1647 | 0.000 |
Why?
|
| Nucleic Acid Conformation | 1 | 1989 | 348 | 0.000 |
Why?
|
| Retroviridae Proteins | 1 | 1987 | 3 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1987 | 25 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1987 | 280 | 0.000 |
Why?
|
| Antibodies | 1 | 1987 | 349 | 0.000 |
Why?
|